Michael I. Schaffer's Insider Trades & SAST Disclosures
Michael I. Schaffer's most recent trade in Psychemedics Corp. was a trade of 375 Common Stock, $.005 Par Value done at an average price of $4.9 . Disclosure was reported to the exchange on May 22, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael I. Schaffer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.93 per share. | 22 May 2023 | 375 | 36,489 (0%) | 0% | 4.9 | 1,849 | Common Stock, $.005 Par Value |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.87 per share. | 15 May 2023 | 337 | 36,864 (0%) | 0% | 4.9 | 1,641 | Common Stock, $.005 Par Value |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Purchase of securities on an exchange or from another person at price $ 4.95 per share. | 16 Dec 2022 | 100 | 37,201 (0%) | 0% | 5.0 | 495 | Common Stock, $.005 Par Value |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.18 per share. | 11 Nov 2022 | 525 | 37,101 (0%) | 0% | 6.2 | 3,245 | Common Stock, $.005 Par Value |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 5,000 | 37,626 (0%) | 0% | 0 | Common Stock, $.005 Par Value | |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.44 per share. | 13 May 2022 | 337 | 32,626 (0%) | 0% | 6.4 | 2,170 | Common Stock, $.005 Par Value |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.50 per share. | 12 Nov 2021 | 612 | 32,883 (0%) | 0% | 8.5 | 5,202 | Common Stock, $.005 Par Value |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 4,500 | 33,495 (0%) | 0% | 0 | Common Stock, $.005 Par Value | |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 18 Nov 2020 | 500 | 26,669 (0%) | 0% | 4.2 | 2,100 | Common Stock, $.005 Par Value |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 7,000 | 26,169 (0%) | 0% | 0 | Common Stock, $.005 Par Value | |
| Psychemedics Corp. | Michael I. Schaffer | VP of Laboratory Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 2,000 | 2,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges